학술논문
Phase III LEAP-010 study: first-line pembrolizumab with or without lenvatinib in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755